The United Laboratories International Holdings Limited (HKG:3933)
Hong Kong · Delayed Price · Currency is HKD 10.54
+0.11 (1.05%)
Apr 2, 2026, 4:08 PM HKT
HKG:3933 Revenue
In the year 2025, The United Laboratories International Holdings had annual revenue of 13.21B CNY, down -3.99%. The United Laboratories International Holdings had revenue of 5.69B in the half year ending December 31, 2025, a decrease of -16.70%.
Revenue
13.21B CNY
Revenue Growth
-3.99%
P/S Ratio
1.41
Revenue / Employee
759.23K CNY
Employees
17,400
Market Cap
20.79B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.21B | -548.31M | -3.99% |
| Dec 31, 2024 | 13.76B | 19.06M | 0.14% |
| Dec 31, 2023 | 13.74B | 2.41B | 21.22% |
| Dec 31, 2022 | 11.33B | 1.63B | 16.81% |
| Dec 31, 2021 | 9.70B | 930.95M | 10.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 299.99B |
| Grand Pharmaceutical Group | 12.28B |
| China Medical System Holdings | 9.14B |
| Simcere Pharmaceutical Group | 8.60B |
| Luye Pharma Group | 7.02B |
| Sunshine Lake Pharma | 3.96B |
| Consun Pharmaceutical Group | 3.80B |
| Sihuan Pharmaceutical Holdings Group | 2.91B |